Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2019 1
2020 1
2021 2
2023 1
2024 2
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Reporting tumor genomic test results to SEER registries via linkages.
Petkov VI, Byun JS, Ward KC, Schussler NC, Archer NP, Bentler S, Doherty JA, Durbin EB, Gershman ST, Cheng I, Insaf T, Gonsalves L, Hernandez BY, Koch L, Liu L, Monnereau A, Morawski BM, Schwartz SM, Stroup A, Wiggins C, Wu XC, Bonds S, Negoita S, Penberthy L. Petkov VI, et al. J Natl Cancer Inst Monogr. 2024 Aug 1;2024(65):168-179. doi: 10.1093/jncimonographs/lgae013. J Natl Cancer Inst Monogr. 2024. PMID: 39102888
BACKGROUND: Precision medicine has become a mainstay of cancer care in recent years. The National Cancer Institute (NCI) Surveillance, Epidemiology, and End Results (SEER) Program has been an authoritative source of cancer statisti …
BACKGROUND: Precision medicine has become a mainstay of cancer care in recent years. The National Cancer Institute …
Long-term cardiovascular disease risk after anthracycline and trastuzumab treatments in US breast cancer survivors.
Vo JB, Ramin C, Veiga LHS, Brandt C, Curtis RE, Bodelon C, Barac A, Roger VL, Feigelson HS, Buist DSM, Bowles EJA, Gierach GL, Berrington de González A. Vo JB, et al. J Natl Cancer Inst. 2024 Aug 1;116(8):1384-1394. doi: 10.1093/jnci/djae107. J Natl Cancer Inst. 2024. PMID: 38718210 Free PMC article.
BACKGROUND: Although breast cancer survivors are at risk for cardiovascular disease (CVD) from treatment late effects, evidence to inform long-term and age-specific cardiovascular surveillance recommendations is lacking. METHODS: We conducted a retrospective cohort …
BACKGROUND: Although breast cancer survivors are at risk for cardiovascular disease (CVD) from treatment late effects, evidence to in …
Feasibility of visualizing cancer incidence data at sub-county level: Findings from 21 National Program of Cancer Registries.
Ellington TD, Werner AK, Henley SJ, Paddock LE, Agovino PK. Ellington TD, et al. Spat Spatiotemporal Epidemiol. 2023 Jun;45:100564. doi: 10.1016/j.sste.2023.100564. Epub 2023 Jan 14. Spat Spatiotemporal Epidemiol. 2023. PMID: 37301586 Free PMC article.
Monitoring cancer incidence data by geography is useful for planning public health activities. However, due to anticipated confidentiality and statistical reliability issues, data on cancer incidence and mortality are more often displayed at a national …
Monitoring cancer incidence data by geography is useful for planning public health activities. However, due to anticipated con …
Linkage between Utah All Payers Claims Database and Central Cancer Registry.
Garvin JH, Herget KA, Hashibe M, Kirchhoff AC, Hawley CW, Bolton D, Sweeney C. Garvin JH, et al. Health Serv Res. 2019 Jun;54(3):707-713. doi: 10.1111/1475-6773.13114. Epub 2019 Jan 24. Health Serv Res. 2019. PMID: 30675913 Free PMC article.
OBJECTIVE: To evaluate the linkage of claims from the Utah All Payers Claims Database (APCD) and Utah Cancer Registry (UCR). DATA SOURCES: Secondary data from 2013 and 2014 Utah APCD and 2013 UCR cases. ...PRINCIPAL FINDINGS: We were able to link 82.4 percent (9441/11 453) …
OBJECTIVE: To evaluate the linkage of claims from the Utah All Payers Claims Database (APCD) and Utah Cancer Registry (UCR). DATA SOU …
The influence of the Affordable Care Act-Dependent Care Expansion on insurance coverage among young cancer survivors in California: an updated analysis.
Abrahão R, Maguire FB, Morris CR, Parikh-Patel A, Parsons HM, Keegan THM. Abrahão R, et al. Cancer Causes Control. 2021 Jan;32(1):95-101. doi: 10.1007/s10552-020-01360-7. Epub 2020 Nov 6. Cancer Causes Control. 2021. PMID: 33156483
PURPOSE: To assess changes in health insurance coverage for young cancer patients pre- and post- the Affordable Care Act-Dependent Care Expansion (ACA-DCE) implementation in California. Further, we examined differences in insurance coverage by socioeconomic and race …
PURPOSE: To assess changes in health insurance coverage for young cancer patients pre- and post- the Affordable Care Act-Depen …
Intervention Mediators in a Randomized Controlled Trial to Increase Colonoscopy Uptake Among Individuals at Increased Risk of Familial Colorectal Cancer.
Brumbach BH, Birmingham WC, Boonyasiriwat W, Walters S, Kinney AY. Brumbach BH, et al. Ann Behav Med. 2017 Oct;51(5):694-706. doi: 10.1007/s12160-017-9893-1. Ann Behav Med. 2017. PMID: 28236077 Free PMC article. Clinical Trial.
PURPOSE: We examined mediators of behavior change in a tailored-risk communication intervention that increased guideline-based colorectal cancer screening among individuals at increased familial risk. METHODS: Participants at increased familial risk for colorectal cance …
PURPOSE: We examined mediators of behavior change in a tailored-risk communication intervention that increased guideline-based colorectal …
Functional germline variants in DNA damage repair pathways are associated with altered survival in adults with glioma treated with temozolomide.
Guerra G, Wendt G, McCoy L, Hansen HM, Kachuri L, Molinaro AM, Rice T, Guan V, Capistrano L, Hsieh A, Kalsi V, Sallee J, Taylor JW, Clarke JL, Almaraz ER, Wiencke JK, Eckel-Passow JE, Jenkins RB, Wrensch M, Francis SS. Guerra G, et al. Neuro Oncol. 2025 Jun 21;27(5):1385-1398. doi: 10.1093/neuonc/noae275. Neuro Oncol. 2025. PMID: 39745907